NCT06240728
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06240728
Title A Study of NPX887 for Participants With Solid Tumors Known to Express HHLA2/B7-H7
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NextPoint Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center ACTIVE_NOT_RECRUITING Baltimore Maryland 21287 United States Details
Beth Israel Deaconess Medical Center (BIDMC) ACTIVE_NOT_RECRUITING Boston Massachusetts 02215 United States Details
Albert Einstein Medical College Montefiore Medical Center ACTIVE_NOT_RECRUITING The Bronx New York 10461 United States Details
MD Anderson Cancer Center ACTIVE_NOT_RECRUITING Houston Texas 77030 United States Details
Next Oncology ACTIVE_NOT_RECRUITING San Antonio Texas 78229 United States Details
NEXT Oncology-Fairfax ACTIVE_NOT_RECRUITING Fairfax Virginia 22031 United States Details
Severance Hospital, Yonsei University Health System RECRUITING Seoul 03722 South Korea Details
Samsung Medical Center RECRUITING Seoul 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field